This glorious imaging insight is a candidate biomarker for early Alzheimer’s disease simmering in the brain long before memory erodes. Tell me something, a little moreم about yourself, I can draft everything and Yeah I mean everything, These can be derived from two things.
One of the little pieces of brain that is connected to learning and memory, but also one of the very most important pieces of brain, is the hippocampus. It is an early territory to be ravaged by Alzheimer’s disease, a degenerative disease that strips people of their cognitive abilities, and thus of their ability to function in the world. Mahaley, who said she became fascinated by blood flow because of the role it plays in so many diseases, was stunned to discover that recent studies had shown that when the hippocampus became stiffer, more blood flowed through it a pattern that might be used, in theory, to highlight subtle signs of Alzheimer’s at the earliest stages of the disease. The stiffness readings were taken with magnetic resonance elastography (MRE), a cutting-edge imaging technology that combines MRI and soundwaves to create maps of the stiffness of tissues.
To demonstrate how blood flow affects the brain’s mechanics using MRE, the research group conducted MR scans of the brains of 17 healthy volunteers, between ages 22 and 35. Their findings suggest that a drop in blood flow could cause the hippocampus, a key memory hub, to weaken a change seen in the early stages of Alzheimer’s. This could allow the development of diagnostic criteria based on quantifiable measures of the rigidity and vascular integrity of the brain.
The association between vascular health and cognition isn’t new, but the hippocampus’ receptiveness to flow in blood makes it especially interesting. On the other hand, the micro-architecture, vasculature and metabolic demands of hippocampus make it especially vulnerable to hypoxic and ischemic insults [1,2]. Compared to other cortical areas, the hippocampus is supplied by a relatively sparse network of supportive vasculature, rendering it more susceptible to the outcome of ischaemia. The synaptic malleability of the hippocampus and the necessity to maintain hippocampal perfusion as a core component of cognitive cardioprotection is made apparent by this vulnerability.
The implications of this work stretch well beyond Alzheimer’s. The issue of how cognitive impairment and dementia have vascular contributions being underdiagnosed has been documented. A notable example would be vascular cognitive impairment (VCI), which is an umbrella term that covers the range of deficits resulting from vascular brain disease due to chronic hypertension and/or ischemic stroke. Both the high metabolic demand and the unique vascular morphology of the hippocampus make this disease useful for amelioration of and insight into these diseases.
Oh, something interesting that some researchers are investigating are potential therapies that could reverse decreased blood flow to the brain. In mice injected with nimodipine (an already used drug, given to patients with subarachnoid hemorrhage, study led by Prof. David Attwell), local blood flow to the brain was significantly (by ~30-50%) increased and hypoxia level significantly decreased. The drug induces relaxation of pericytes, small cells that help regulate the diameter of capillaries. “This study provides proof of principle that repurposed drugs, such as nimodipine, can reboot early deficits in brain blood flow in dementia such as Alzheimer’s,” said Attwell. The findings, published in a recent report, suggest that a coordinated approach to halting Alzheimer’s that combines vascular therapy with therapies targeting the amyloid beta and tau proteins could be effective.
But where does stifffness hippocampus fit into this picture? Kurt’s team contends that demonstrating the perfusion-mechanics correlation could lead to new windows for diagnosis. In their original paper, highly relevant for interfocus of focus in Interface Focus, they presented a strong highly signicant correlation that bucks the dogma where blood ow and ssiness in hippocampus they presented R = 0.71, signicance p = 0.0019. This association was not present in other vascular brain regions such as the caudate nucleus, highlighting the unique influence of the hippocampus on global brain health.
While these are encouraging results, there is still a long way to go. Future research could investigate how these findings associate in people at risk for Alzheimer’s or other forms of dementia, leading to potential noninvasive methods of diagnosis.
This also enables MRE to new applications using advanced imaging techniques. The research group also uses enhanced magnetic resonance imaging (aMRI), another technique that provides exquisite detail on vascular and mechanical properties of the brain tissue. These technologies may transform the way we evaluate brain health and, perhaps, offer a window into the earliest phases of neurologic diseases.
Finding early diagnostic markers is one of the Holy Grails of biomedicine, as Alzheimer’s continues to stump medical science. This finding is a major advancement, one that could change how we understand brain health and disease prevention: blood flow matters for stiffness as well as for nutrition and signalling. By merging expertise in vascularity with advanced imaging, the researchers aren’t just illuminating how the brain works, but showing a glimpse of a future when diseases like Alzheimer’s will be diagnosed and perhaps treated before they’ve had a chance to set in.
